CDP-571

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCDP-571
Drug Alias NameCDP-571cb-0010BAY-10-3356
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionTumor necrosis factor α inhibitorsImmunosuppressants
TargetsTumor necrosis factor α
Therapy Area/IndicationsDiabetes Mellitus, Type 2Crohn DiseaseArthritis, Rheumatoid +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCelltech
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCelltechBiogen Inc
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 2Crohn DiseaseArthritis, Rheumatoid +[4] 

Other Information

ATC CodeN/A
Related LinksN/A